Please assess the completion status of the following clinical trial:

Trial Title: Impact of Weight Loss on Gastroesophageal Reflux Disease in Overweight and Obese Subjects: a Prospective Study

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Must be a Kansas City Veterans Hospital patient who is enrolled in the MOVE weight loss program~* Patients with a BMI \> 25 with associated co-morbid medical conditions such as diabetes, high blood pressure, high cholesterol, arthritis, heart disease, low back pain, sleep apnea, or other obesity associated condition.~* Enrollment in MOVE program is optional for patients with a BMI \> 25 with no co-morbid medical conditions.~* Enrollment for patients 70 years or older with BMI \> 25 is optional and requires mandatory medical clearance prior to beginning new physical activity and closer nutritional supervision to minimize protein, vitamin and mineral deficiencies.~Exclusion Criteria:~* Active cancer other than non-melanoma skin cancer~* End stage COPD, congestive heart failure~* End stage neurologic disorder (Parkinson's, ALS, MS)~* Long-term care facility resident~* End stage renal disease~* Moderate to severe cognitive impairment (dementia, post-stroke)~* Active psychosis or substance abuse~* AIDS (except asymptomatic HIV infection)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Obese individuals with weight loss (Type: EXPERIMENTAL): Self support, group sessions
- Obese individuals without weight loss (Type: EXPERIMENTAL): self support, group sessions

Based on this trial design, predict the completion outcome and termination type (if applicable).